Another possibility is that the elevated TSG-6 in BPD (a pathological condition) is because of enhanced inflammation reaching its threshold to the therapeutic level once the MSC-CM/EXO treatment is done. The gene discussed is TNFAIP6; the disease is bronchopulmonary dysplasia.